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As has already been reported) the anti-icteroides immune serum is 
capable  of  protecting  susceptible  animals  against  infection  with 
Leptospira  icteroides when administered simultaneously or during the 
early period of  the disease.  Lyster,  Pareja,  Bailey,  Vaughn,  Vas- 
concelos, Casasus, Iglesias, Loyo, Le Blanc, Lynn and his associates, 
Hernandez,  Lara,  Villamil,  Kllgler,  and  Gann  2  have  found  that 
the mortality among human cases of yellow fever treated with  the 
immune serum on or before the 3rd  day of disease is much  lower 
than  that  among untreated  cases.  Of  71  cases treated within the 
first 3 days of disease in Guatemala, Salvador, Honduras, Vera Cruz 
Merida, and northern Peru only 5  died (7 per cent mortality); the 
results of serum treatment were less favorable in the Tuxpam (Mexico) 
epidemic, where  the mortality among the  treated was  25  per cent 
(9 deaths among 36 cases), but here the mortality among untreated 
cases  was  correspondingly higher,  being  68.6  per  cent  (59  deaths 
a Noguchi, H., Serum treatment of animals infected with Leptospira  icteroides 
J. Exp. Med.,  1920, x.x.xl, 159; Chemotherapy  versus serotherapy in experimental 
infection with Leptospira icteroides, 1920, xxxii, 381.  Noguchi, H., and Kligler, 
I.J.,  Immunological  studies with a strain of leptospira isolated from a case of 
yellow fever in Merida, Yucatan, J. Exp. Med.,  1920, xxxii, 627; Immunology  of 
the Peruvian strains of Leptospira icteroides, 1921; xxxiii, 253. 
t Noguehi, H., Prophylaxis  and serum  therapy of yellow fever, J. Am. Meal. 
Assn.,  1921, lxxvii, 181.  See also the report of The Rockefeller Foundation for 
the year 1921. 
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among 86 cases).  Of the total 187 cases treated to date, 107 received 
the serum on or before the 3rd day, and of these, only 14 died (mor- 
tality 13 per cent); on the other hand, there have been 41 deaths (51 
per cent mortality) among 80 cases treated on or after the 4th day, 
and 225  deaths (56.6 per cent mortality) among 397  untreated cases 
occurring in the same localities during the same epidemic periods. 
The serum has apparently undoubted therapeutic value in human 
cases of yellow fever as well as in cases of experimental infection with 
Leptospira  ict~roi,  des  in  animals.  Vaccination  by  means  of  killed 
cultures of Leptosplra icteroides  (injected in two subcutaneous injec- 
tions of 2 cc. each, 4 to 6 days apart) has been shown to confer com- 
plete protection within 10 to 15 days of the last inoculation.  2,a  Dur- 
ing the period required for development of active immunity, however, 
anti-icteroides  serum might be utilized for the immediate protection 
of non-lmmune individuals who find themselves in an  epidemic or 
endemic focus of yellow fever, or it might be substituted for vaccina- 
tion in the case of persons who intend only to pass through an infected 
district.  It is well known that an immune serum or antitoxin, when 
introduced into the system of a non-immune individual, will protect 
against infection for a period which varies from a few to many days 
according to the number of units of immune bodies initially introduced 
and the rate  of elimination of such bodies from the inoculated in- 
dividual.  The  passive  immunity thus  conferred  is  necessarily  of 
short duration, yet the employment of anti-icteroides  serum for the 
temporary protection of non-immune individuals might be  of con- 
siderable practical value. 
In the experiments to be reported here guinea pigs were used to 
determine the duration of the protective effect of an injection of anti- 
icteroides immune serum. 
EXPERIMENTAL. 
Six different doses of immune serum (0.00001,  0.0001, 0.001, 0.01, 
0.1, and 1 cc.) were subcutaneously inoculated into six sets (two each) 
of guinea pigs of about 500 gm. body weight.  The tests for the per- 
*  Noguchi, H., and Pareja, W., Prophylactic inoculation against yellow fever, 
J. Am. Med. Assn., 1921, lxxvi, 96. HIDEY0 NOGUCHI  359 
sistence of passive immunity were made 1, 2, 3, 4, 5, 7,  10, and 15 
days after the injection of the immune serum.  In order to infect all 
the guinea pigs, including six normal control animals, with the same 
material at the same time, the injections of the immune serum were 
begun 15 days before the time selected for the test inoculation of a 
virulent strain of Leptospira  icteroides.  The infective material used 
was an emulsion of the liver and kidneys of a guinea pig fatally in- 
fected with a  strain of Leptospira  icteroides isolated in Morropon by 
Noguchi and Kligler,  4 which killed the control guinea pigs within 9 
to  10 days in  quantities of 0.001,  0.01,  and 0.1  cc.  0.1  cc.  of the 
emulsion, representing about 100 minimum lethal doses, was used in 
this  experiment  and  was  given  subcutaneously.  The  results  are 
recorded in Table I. 
Analysis of the table shows that the minimum quantity of anti- 
icteroides serum required for protection, as revealed by  the results 
obtained when the serum was given an hour previous to the inocula- 
tion of the infecting material, lay between 0.00001  and 0.0001  cc. 
Judged from the survival of three guinea pigs which received serum 
24,  48,  and  72  hours previously the protective titer  of the  serum 
must be close to 0.0001 cc.  There was no diminution  in the protective 
effect within 48 hours, but after 3, 4, and 5 days 0.0001  cc. no longer 
gave complete protection, while 0.001 cc. protected in every instance. 
7 days after the time of injection of the serum 0.001 cc. failed to pro- 
tect, but 0.01 cc. was still effective.  After the lapse of 10 days 0.1 cc. 
was required to prevent infection, and after 15 days only those animals 
which had received 1 cc.  of the immune serum withstood infection. 
The rate of elimination of the immune substance in the body of the 
guinea pig after the subcutaneous introduction of the anti-icteroides 
serum does not proceed uniformly in  the successive days following 
injection, but follows a  characteristic course which may be roughly 
estimated in the manner shown in Text-fig. 1,  the unit being 0.0001 
cc.,  which neutralized  at  least  100  minimum  lethal  doses in  the 
present series. 
The rate of disappearance of the immune substance is very slow at 
first, but becomes rapid after about  10 days.  This phenomenon is 
4Noguchi, H., and Kligler, I. J.,  Experimental studies on yellow fever in 
northern Peru, J. Exp. Med., 1921, xxxiii, 239. 360  ETIOLOGY  OF  YELLOW  FEVEI~.  XIV 
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not  characteristic  of  anti-icteroides  serum  alone,  because  various 
immune  serums  appear  to  undergo  a  similar  reduction  in  strength 
when introduced into different species of animals.  Knott, forexample, 
found that tetanus antitoxin (horse serum), given to a foreign species 
(guinea pigs or rabbits), is reduced  rapidly and that  only  about ~-~ 
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TXxT-FIo. 1.  Curve showing the increase in amount of anti-icteroides serum 
(in units) necessary for protection according to the length of time elapsing after 
administration. 
of the quantity originally present in the blood can be demonstrated 
after  12  to  14  days.  5  Tizzoni s  obtained  similar  results.  Nocard  7 
estimated that the longest period that the tetanus antitoxin remains 
Knorr, A.,  Das Tetanusgift  und seine Beziehungen rum thierischen Organis- 
mus.  Eine  experimentelle  Studie  fiber Krankheit  und Heilung, Mt~nch. rned. 
Woch., 1898, xlv, 362; Die Entstehung  des Tetanusanfitoxins im ThierkSrper und 
seine Beziehung rum Tetanusgift, Fortschr. Med., 1897, xv, 657. 
6  Tizzoni, G., Sull' efficacia  dell' anfitossina nel trattamento  prevenfivo contro 
il tetano dopo awenuto l'infezione, Gazz. osp., 1897, xviii, 1215. 
7 Nocard, E., Sur la s6roth6rapie du t6tanos;  essais de traitement  prevenfif, 
Bull. Acad. reed., 1895, xxxiv, 407. Hm~.~O Noovc~x  363 
in the body is about 4  to 6 weeks.  Pfeiffer and Friedberge# found 
that when an anticholera serum derived from the goat is injected into 
the rabbit it gives rise to an anti-immune substance by which it is 
neutralized in a comparatively short time.  Ransom and Kitashima  ° 
showed  that  homologous tetanus  antitoxin,  when  injected  into  a 
normal horse, may remain as long as 80 days; that is, the duration of 
the passive immunity is almost as long as that of active immunity. 
On  the  other hand,  J6rgensen  and  Madsen found that not all ho- 
mologous immune serums remain  for  a  long period in the body of 
the injected animal, but that the length of time varies  with  different 
animal  species.10  Kraus  and  his  coworkers  failed  to  demonstrate 
any evidence for the  formation of an anti-immune substance in the 
blood or organs  of  animals  which  had  received  an  injection  of  a 
heterologous  diphtheria antitoxin,  n  Perhaps the sudden disappearance 
of the immune substance after about  10  days in the present series 
of experiments may be intimately connected with the precipitin form- 
ation  for  the  heterologous  anti-icteroides  horse serum.  Moreover, 
the titer of the immune serum is  certain  to  suffer  reduction when 
kept at a  temperature of 39°C., even in vitro, and may be  expected 
to undergo similar reduction in the blood of a foreign species. 
S~ARY. 
Analysis of the records of instances in which non-immune persons 
contracted yellow fever notwithstanding vaccination shows that the 
onset of disease occurs soon after vaccination, the longest period being 
13 days.  Since the average incubation period in yellow fever is 6 days, 
it  seems  that  infection must  have  taken  place  in  some instances 
during the period while protection was developing.  These instances 
s Pfeiffer, R., and Friedberger,  E., Ueber  den Verbleib der bacteriolytischen 
lmmunk~rper im tierischen Organismus nach der passiven Immunisierung,  Cen~r. 
Bakt., 1re AbL, Orig., 1904, xxxvii, 131. 
9 Ransom, F., The conditions which influence the duration of passive immunity, 
J. Path. and Bact.,  1900, vi, 180. 
10 J/irgensen, A., and Madsen, T.,  The fate of typhoid and cholera agglutinins 
during active and passive  immunisation,  Festskrift  red  Indvielsen  af Statens 
Serum-Institut, 1902, Copenhagen, Paper 6. 
11 Kraus, R., and Joachim, J., Zur Frage der passiven Immunisierung, Wign. klln. 
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led to a study of the possibility of immediate protection by means of 
the anti-icteroides  serum.  It had already been shown that the im- 
mune serum protects at once against experimental Leptospira icteroides 
infection, but it remained to determine how long the protection would 
last. 
Guinea pigs were given different quantities of the immune serum 
and subsequently injected, at various intervals, with a virulent strain 
of Leptospira  icteroides.  Complete protection enduring 5 days was 
obtained with as minute a  quantity of serum as 0.002 cc. per 1,000 
gin.  of body weight.  After 5 days, however, the immune substance 
rapidly diminished~ and to keep the animal protected for as long as 
10 days it was necessary to give 100 times as much, or 0.2 cc.  For 
a man weighing 80 kilos, 0.16 cc. (0.002 X  80) would theoretically be 
sufficient to protect for at least 5 days, 1.6 cc. for 7 days, and 16 cc. 
for 10 days.  This temporary  protection may be a valuable antecedent 
to that furnished by vaccination, since the final effect of the latter 
cannot be expected until at least 9 to 10 days have passed. 